Αποτελέσματα Αναζήτησης
Treatment of Blind Patients with Non-24 h Sleep–Wake Rhythm Disorder. Treatment of totally blind patients suffering from non-24 SWRD is considered effective when circadian rhythms are entrained to a normal 24 h cycle.
31 Οκτ 2015 · Here we present the results of two phase 3 clinical trials to determine the efficacy and safety of daily tasimelteon administration for totally blind patients with non-24.
14 Ιουν 2024 · Diagnosing N24SWD involves assessing your sleep patterns over an extended period. This is typically done using sleep diaries and actigraphy, which is a method of monitoring rest and activity...
The first detailed study of non-24 in a blind subject was by Miles Le and his colleagues in 1977. The researchers reported on a 28-year-old male who had a 24.9-hour rhythm in sleep, plasma cortisol, and other parameters.
31 Οκτ 2015 · In two consecutive placebo-controlled trials (SET and RESET), we assessed safety and efficacy (in terms of circadian entrainment and maintenance) of once-daily tasimelteon, a novel dual-melatonin receptor agonist.
22 Φεβ 2017 · Orally administered melatonin and the melatonin agonist tasimelteon have been shown to entrain (synchronize) the circadian clock, resulting in improvements in night-time sleep and daytime alertness. We review the basic principles of circadian rhythms necessary to understand and treat non-24.
Non–24-hour sleep–wake rhythm disorder (N24SWD) is a debilitating cyclic circadian rhythm sleep disorder characterized by an inability to sleep on a 24-hour schedule. N24SWD is rare in sighted individuals and has multiple possible causes including behavioral, sleep-wake regulation or genetic causes.
